Biodexa Pharmaceuticals Plc — Regulatory Filings 2020

Aug 11, 2020

CORRESP 1 filename1.htm

Midatech Pharma PLC

Oddfellows House

19 Newport Road

Cardiff, CF24 0AA

United Kingdom

August 11, 2020

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Laura Crotty

Re: Midatech Pharma PLC

Registration Statement on Form F-1, as amended (File No. 333-240984)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Midatech Pharma PLC (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form F-1 (as amended to date, the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m., Eastern Time, on August 13, 2020, or as soon as practicable thereafter.

[Signature Page Follows]

Field: Page; Sequence: 1

Field: /Page

Very truly yours,
MIDATECH PHARMA PLC
By:	/s/ Stephen Stamp
Name:	Stephen Stamp
Title:	Chief Executive Officer & Chief Financial Officer

Field: Rule-Page

Field: /Rule-Page